Compare $INTS vs $ZEOX | Chartloom

Compare

$INTS vs $ZEOX

Intensity Therapeutics Inc · ZEO ScientifiX Inc

INTS

Intensity Therapeutics Inc

ZEOX

ZEO ScientifiX Inc

Compare $INTS vs $ZEOX

Comparing Intensity Therapeutics Inc and ZEO ScientifiX Inc

INTSIntensity Therapeutics Inc

ZEOXZEO ScientifiX Inc

INTSIntensity Therapeutics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-64.3%

52W performance

-49.1%

FCF yield

-91.4%

ZEOXZEO ScientifiX Inc

Market cap

$9M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

52.8%

YTD performance

-55.7%

52W performance

-16.5%

FCF yield

-14.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

INTS

ZEOX

Detailed metrics comparison

INTS

Intensity Therapeutics Inc

ZEOX

ZEO ScientifiX Inc

Market Cap

INTS$10M

ZEOX$9M

Enterprise Value

INTS$272K

ZEOX$8M

Price

INTS$3.63

ZEOX$1.19

P/E Ratio

INTSN/A

ZEOXN/A

P/S Ratio

INTS0.00x

ZEOX1.33x

EV/Sales

INTS0.00x

ZEOX1.11x

EV/EBITDA

INTS0.00x

ZEOX0.00x

P/B Ratio

INTS1.22x

ZEOX16.07x

P/FCF Ratio

INTSN/A

ZEOXN/A

EV/FCF

INTS-0.03x

ZEOX-5.77x

PEG Ratio

INTSN/A

ZEOXN/A

Forward P/E (NTM)

INTSN/A

ZEOXN/A

Forward P/S (NTM)

INTSN/A

ZEOXN/A

Revenue (TTM)

INTS$0

ZEOX$7M

Revenue Growth (YoY)

INTSN/A

ZEOX52.8%

Forward Rev Growth

INTS506.0%

ZEOX0.0%

Gross Margin (TTM)

INTS0.0%

ZEOX81.5%

Operating Margin (TTM)

INTS0.0%

ZEOX0.0%

EBITDA Margin (TTM)

INTS0.0%

ZEOX-58.0%

Net Margin (TTM)

INTS0.0%

ZEOX-55.6%

FCF Margin (TTM)

INTSN/A

ZEOX-19.3%

Net Income (TTM)

INTS$-11M

ZEOX$-4M

FCF (TTM)

INTS$-9M

ZEOX$-1M

EPS (TTM)

INTS-$4.12

ZEOX-$0.50

ROE (TTM)

INTS-11661.0%

ZEOX0.0%

ROA (TTM)

INTS-9401.0%

ZEOX-16123.0%

ROIC (TTM)

INTS-11661.0%

ZEOX0.0%

Cash

INTS$10M

ZEOX$2M

Debt

INTS$0

ZEOX$343K

Net Cash/Debt

INTS$10M

ZEOX$2M

Current Ratio (TTM)

INTS5.00x

ZEOX1.05x

Quick Ratio (TTM)

INTS4.24x

ZEOX0.68x

Debt/Equity (TTM)

INTS0.00x

ZEOX0.48x

Debt/Assets (TTM)

INTS0.0%

ZEOX0.0%

Interest Coverage (TTM)

INTSN/A

ZEOXN/A

Net Debt/EBITDA (TTM)

INTS0.00x

ZEOX0.00x

Beta

INTS3.02

ZEOX1.94

52W Performance

INTS-49.1%

ZEOX-16.5%

YTD Performance

INTS-64.3%

ZEOX-55.7%

% from 52W High

INTS-91.7%

ZEOX-60.4%

% from 52W Low

INTS13.1%

ZEOX22.2%

Asset Turnover (TTM)

INTS0.00x

ZEOX2.90x

FCF Yield (TTM)

INTS-91.4%

ZEOX-14.5%

Earnings Yield (TTM)

INTS-113.9%

ZEOX-41.8%

Dividend Yield (TTM)

INTSN/A

ZEOXN/A

Rule of 40

INTS0.0

ZEOX33.4

EV/GP/RG

INTSN/A

ZEOXN/A

Ticker research

View INTS research View ZEOX research

Metric	INTS Intensity Therapeutics Inc	ZEOX ZEO ScientifiX Inc
Market & Valuation
Market Cap	$10M	$9M
Enterprise Value	$272K	$8M
Price	$3.63	$1.19
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1.33x
EV/Sales	0.00x	1.11x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.22x	16.07x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.03x	-5.77x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$7M
Revenue Growth (YoY)	N/A	52.8%
Forward Rev Growth	506.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	81.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-58.0%
Net Margin (TTM)	0.0%	-55.6%
FCF Margin (TTM)	N/A	-19.3%
Net Income (TTM)	$-11M	$-4M
FCF (TTM)	$-9M	$-1M
EPS (TTM)	-$4.12	-$0.50
ROE (TTM)	-11661.0%	0.0%
ROA (TTM)	-9401.0%	-16123.0%
ROIC (TTM)	-11661.0%	0.0%
Financial Health
Cash	$10M	$2M
Debt	$0	$343K
Net Cash/Debt	$10M	$2M
Current Ratio (TTM)	5.00x	1.05x
Quick Ratio (TTM)	4.24x	0.68x
Debt/Equity (TTM)	0.00x	0.48x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.02	1.94
52W Performance	-49.1%	-16.5%
YTD Performance	-64.3%	-55.7%
% from 52W High	-91.7%	-60.4%
% from 52W Low	13.1%	22.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	2.90x
FCF Yield (TTM)	-91.4%	-14.5%
Earnings Yield (TTM)	-113.9%	-41.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	33.4
EV/GP/RG	N/A	N/A
Ticker research	View INTS research	View ZEOX research

Valuation

P/S Ratio

INTS

0.00x

ZEOX

1.33x

EV/FCF

ZEOX

-5.77x

INTS

-0.03x

Growth & revenue

Revenue Growth TTM

ZEOX

52.8%

Forward Revenue Growth

INTS

506.0%

ZEOX

0.0%

Profitability & performance

Gross Margin

ZEOX

81.5%

INTS

0.0%

ROE

ZEOX

0.0%

INTS

-11661.0%

FCF Yield %

ZEOX

-14.5%

INTS

-91.4%

52-Week Performance

ZEOX

-16.5%

INTS

-49.1%

Detailed metrics comparison

INTS

Intensity Therapeutics Inc

ZEOX

ZEO ScientifiX Inc

Market Cap

INTS$10M

ZEOX$9M

Enterprise Value

INTS$272K

ZEOX$8M

Price

INTS$3.63

ZEOX$1.19

P/E Ratio

INTSN/A

ZEOXN/A

P/S Ratio

INTS0.00x

ZEOX1.33x

EV/Sales

INTS0.00x

ZEOX1.11x

EV/EBITDA

INTS0.00x

ZEOX0.00x

P/B Ratio

INTS1.22x

ZEOX16.07x

P/FCF Ratio

INTSN/A

ZEOXN/A

EV/FCF

INTS-0.03x

ZEOX-5.77x

PEG Ratio

INTSN/A

ZEOXN/A

Forward P/E (NTM)

INTSN/A

ZEOXN/A

Forward P/S (NTM)

INTSN/A

ZEOXN/A

Revenue (TTM)

INTS$0

ZEOX$7M

Revenue Growth (YoY)

INTSN/A

ZEOX52.8%

Forward Rev Growth

INTS506.0%

ZEOX0.0%

Gross Margin (TTM)

INTS0.0%

ZEOX81.5%

Operating Margin (TTM)

INTS0.0%

ZEOX0.0%

EBITDA Margin (TTM)

INTS0.0%

ZEOX-58.0%

Net Margin (TTM)

INTS0.0%

ZEOX-55.6%

FCF Margin (TTM)

INTSN/A

ZEOX-19.3%

Net Income (TTM)

INTS$-11M

ZEOX$-4M

FCF (TTM)

INTS$-9M

ZEOX$-1M

EPS (TTM)

INTS-$4.12

ZEOX-$0.50

ROE (TTM)

INTS-11661.0%

ZEOX0.0%

ROA (TTM)

INTS-9401.0%

ZEOX-16123.0%

ROIC (TTM)

INTS-11661.0%

ZEOX0.0%

Cash

INTS$10M

ZEOX$2M

Debt

INTS$0

ZEOX$343K

Net Cash/Debt

INTS$10M

ZEOX$2M

Current Ratio (TTM)

INTS5.00x

ZEOX1.05x

Quick Ratio (TTM)

INTS4.24x

ZEOX0.68x

Debt/Equity (TTM)

INTS0.00x

ZEOX0.48x

Debt/Assets (TTM)

INTS0.0%

ZEOX0.0%

Interest Coverage (TTM)

INTSN/A

ZEOXN/A

Net Debt/EBITDA (TTM)

INTS0.00x

ZEOX0.00x

Beta

INTS3.02

ZEOX1.94

52W Performance

INTS-49.1%

ZEOX-16.5%

YTD Performance

INTS-64.3%

ZEOX-55.7%

% from 52W High

INTS-91.7%

ZEOX-60.4%

% from 52W Low

INTS13.1%

ZEOX22.2%

Asset Turnover (TTM)

INTS0.00x

ZEOX2.90x

FCF Yield (TTM)

INTS-91.4%

ZEOX-14.5%

Earnings Yield (TTM)

INTS-113.9%

ZEOX-41.8%

Dividend Yield (TTM)

INTSN/A

ZEOXN/A

Rule of 40

INTS0.0

ZEOX33.4

EV/GP/RG

INTSN/A

ZEOXN/A

Ticker research

View INTS research View ZEOX research

Metric	INTS Intensity Therapeutics Inc	ZEOX ZEO ScientifiX Inc
Market & Valuation
Market Cap	$10M	$9M
Enterprise Value	$272K	$8M
Price	$3.63	$1.19
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1.33x
EV/Sales	0.00x	1.11x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.22x	16.07x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.03x	-5.77x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$7M
Revenue Growth (YoY)	N/A	52.8%
Forward Rev Growth	506.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	81.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-58.0%
Net Margin (TTM)	0.0%	-55.6%
FCF Margin (TTM)	N/A	-19.3%
Net Income (TTM)	$-11M	$-4M
FCF (TTM)	$-9M	$-1M
EPS (TTM)	-$4.12	-$0.50
ROE (TTM)	-11661.0%	0.0%
ROA (TTM)	-9401.0%	-16123.0%
ROIC (TTM)	-11661.0%	0.0%
Financial Health
Cash	$10M	$2M
Debt	$0	$343K
Net Cash/Debt	$10M	$2M
Current Ratio (TTM)	5.00x	1.05x
Quick Ratio (TTM)	4.24x	0.68x
Debt/Equity (TTM)	0.00x	0.48x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.02	1.94
52W Performance	-49.1%	-16.5%
YTD Performance	-64.3%	-55.7%
% from 52W High	-91.7%	-60.4%
% from 52W Low	13.1%	22.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	2.90x
FCF Yield (TTM)	-91.4%	-14.5%
Earnings Yield (TTM)	-113.9%	-41.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	33.4
EV/GP/RG	N/A	N/A
Ticker research	View INTS research	View ZEOX research